|
Core Support for Cancer Center
|
2P30CA013330-40
|
$3,589,611
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-40S1
|
$75,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Targeting PML for therapy in leukemia-initiating cells
|
5R00CA139009-04
|
$234,060
|
Ito, Keisuke
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Targeting PML for leukemia therapy.
|
5R01CA142874-04
|
$425,460
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Rapid Testing of Drug Resistant BCR-ABL(+) Leukemia Cells
|
2R44CA153614-02
|
$613,119
|
Rieder, Ronald
|
BIOSENSE TECHNOLOGIES, INC.
|
|
Cancer and Leukemia Group B Human Specimen Repositories
|
5U24CA114725-09
|
$1,086,261
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-23
|
$4,740,480
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-23S2
|
$37,026
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cell signaling as a leukemia biomarker
|
5R21CA158659-02
|
$160,494
|
JACOBBERGER, JAMES
|
CASE WESTERN RESERVE UNIVERSITY
|
|
MOLECULAR STUDIES OF BONE MARROW FAILURE
|
5R01CA105312-08
|
$544,060
|
BESSLER, MONICA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Improved therapeutic approaches for hematological disorder treated with tyrosine
|
5R01CA155091-02
|
$298,427
|
Azam, Mohammad
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Nonadherence: Undermining health outcomes in pediatric HSCT?
|
5R01CA157460-02
|
$479,328
|
PAI, AHNA
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-03
|
$298,427
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Fanconi Anemia and HPV Transformation
|
5R01CA102357-09
|
$275,896
|
Wells, Susanne
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Microenvironmental Regulation of Leukemia Stem Cells
|
1R01CA172447-01A1
|
$348,600
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Resistance of CML Stem Cells to Imatinib (Gleevec)
|
2R01CA095684-10
|
$314,718
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Roles of SIRT1 in normal hematopoietic and leukemic stem cells
|
5R01CA143421-03
|
$294,916
|
CHEN, WENYONG
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA033572-30
|
$2,042,489
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-30S1
|
$125,000
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-30S2
|
$52,354
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-30S3
|
$10,680
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-02
|
$327,684
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Optimizing decitabine regimen + formulation for nonDNA damaging DNMT1 depletion
|
5R01CA138858-05
|
$300,166
|
Saunthararajah, Yogen
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
CSHL CANCER CENTER SUPPORT GRANT
|
5P30CA045508-26
|
$4,077,038
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Role of Dok-1 in oncogenic tyrosine kinase signaling
|
5R01CA135053-05
|
$357,586
|
VAN AELST, LINDA
|
COLD SPRING HARBOR LABORATORY
|
|
Molecular Pathways to Thynmic Lymphoma and Leukemia
|
5P01CA109901-09
|
$1,895,397
|
LOOK, A
|
DANA-FARBER CANCER INST
|
|
Evolutionary Dynamics of Brain, Lung, and Hematopoietic Tumors
|
5U54CA143798-05
|
$2,127,452
|
Michor, Franziska
|
DANA-FARBER CANCER INST
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-39S1
|
$18,744
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-39
|
$5,351,774
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Inhibition of Cytochrome c-induced Caspase Activation
|
5R01CA102707-09
|
$247,272
|
KORNBLUTH, SALLY
|
DUKE UNIVERSITY
|
|
Engineering tyrosine kinase-activated caspases for selective cancer cell killing
|
5R01CA153126-04
|
$231,878
|
KORNBLUTH, SALLY
|
DUKE UNIVERSITY
|
|
Molecular Pathogenesis of Monoclonal B Cell Lymphocytosis and CLL
|
5K08CA134919-03
|
$161,137
|
Lanasa, Mark
|
DUKE UNIVERSITY
|
|
Adult Leukemia Research Center
|
5P01CA018029-38
|
$3,971,921
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CAN RES CTR
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-03
|
$170,100
|
Bleakley, Marie
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S1
|
$109,383
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S2
|
$18,750
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S3
|
$125,000
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S4
|
$50,000
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-39
|
$10,072,717
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
Integrating Diagnostics with Therapeutic Strategies in Chronic Myeloid Leukemia
|
5R01CA140371-05
|
$332,990
|
Oehler, Vivian
|
FRED HUTCHINSON CAN RES CTR
|
|
Bone Marrow Transplantation for Hematologic Malignancies using Novel Radioimmunot
|
3R01CA138720-04S1
|
$38,657
|
PAGEL, JOHN
|
FRED HUTCHINSON CAN RES CTR
|
|
Bone Marrow Transplantation for Hematologic Malignancies using Novel Radioimmunot
|
5R01CA138720-04
|
$332,990
|
PAGEL, JOHN
|
FRED HUTCHINSON CAN RES CTR
|
|
Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
|
1R01CA175215-01
|
$646,486
|
Radich, Jerald
|
FRED HUTCHINSON CAN RES CTR
|
|
Development of GZ38-1, a Novel Protectant of Chemotherapy-Induced Myelosuppressio
|
1R44CA174074-01A1
|
$151,115
|
Strum, Jay
|
G1 THERAPEUTICS, INC.
|
|
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
|
5R01CA154244-09
|
$365,317
|
Korngold, Robert
|
HACKENSACK UNIVERSITY MEDICAL CENTER
|
|
Role of Setbp1 in leukemic stem cell self-renewal
|
5R01CA143193-04
|
$289,474
|
Du, Yang
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
|
MPD Research Consortium
|
5P01CA108671-07
|
$3,842,401
|
Hoffman, Ronald
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis
|
5R01CA134777-03
|
$300,377
|
CHAN, REBECCA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-14S3
|
$1,156,983
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-14S4
|
$74,999
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|